We are live on ! Find out more
CSLT

CASTLIGHT HEALTH, INC.

Delisted

CSLT was delisted on the 16th of February, 2022.

99 hedge funds and large institutions have $115M invested in CASTLIGHT HEALTH, INC. in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 35 increasing their positions, 31 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 31

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

12% less funds holding

Funds holding: 11299 (-13)

52% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 23

56% less capital invested

Capital invested by funds: $259M → $115M (-$144M)

Holders
99
Holders Change
-13
Holders Change %
-11.61%
% of All Funds
2.17%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
11
Increased
35
Reduced
31
Closed
23
Calls
$23K
Puts
Net Calls
+$23K
Net Calls Change
-$59K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$666K +$431K +216,080 +84%
HP
27
Harbourvest Partners
Massachusetts
$492K
N
28
Nuveen
North Carolina
$489K -$167K -83,876 -19%
Bank of New York Mellon
29
Bank of New York Mellon
New York
$489K -$19.9K -9,982 -3%
Morgan Stanley
30
Morgan Stanley
New York
$458K +$472K +236,921 +270%
Squarepoint
31
Squarepoint
New York
$456K +$322K +161,715 +100%
Russell Investments Group
32
Russell Investments Group
United Kingdom
$427K -$133K -66,509 -18%
HSBC Holdings
33
HSBC Holdings
United Kingdom
$410K +$580K +290,809 New
PM
34
Penbrook Management
New York
$368K -$4.98K -2,500 -0.9%
OAM
35
Oxford Asset Management
United Kingdom
$366K -$615K -308,782 -54%
Citadel Advisors
36
Citadel Advisors
Florida
$329K +$257K +128,976 +124%
PAM
37
Panagora Asset Management
Massachusetts
$299K
Swiss National Bank
38
Swiss National Bank
Switzerland
$230K +$30.3K +15,200 +10%
AO
39
Allen Operations
New York
$222K
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$219K
Goldman Sachs
41
Goldman Sachs
New York
$200K -$623K -312,552 -69%
BCM
42
Bridgeway Capital Management
Texas
$200K -$174K -87,500 -38%
CCM
43
Concourse Capital Management
Georgia
$200K +$149K +74,537 +110%
EWM
44
Edge Wealth Management
New York
$194K -$1.99K -1,000 -0.7%
AllianceBernstein
45
AllianceBernstein
Tennessee
$184K -$1.59K -800 -0.6%
HF
46
HRT Financial
New York
$178K +$253K +126,897 New
UBS Group
47
UBS Group
Switzerland
$173K +$81.1K +40,700 +49%
VCA
48
VIEX Capital Advisors
Florida
$170K +$241K +120,901 New
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$162K -$1.54K -775 -0.7%
UBS AM
50
UBS AM
Illinois
$155K +$9.28K +4,655 +4%

CSLT Hedge Fund Activity: Q3 2019 in Review

99 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in CASTLIGHT HEALTH, INC. (CSLT) for Q3 2019, worth a combined $115M — down 56% from $259M a quarter earlier.

Sellers outnumbered buyers: 23 funds closed out of CSLT and 11 opened new positions — a net loss of 12 holders — while 31 trimmed existing stakes and 35 added.

The largest buyer was Raging Capital Management, opening a new position worth an estimated $10.3M. The largest seller was Paradigm Capital Management Inc, exiting entirely with an estimated $3.02M sold.

  • 99 institutional investors held CASTLIGHT HEALTH, INC. (CSLT) as of Q3 2019, down from 112 in Q2 2019.
  • Funds reported $115M of CASTLIGHT HEALTH, INC. stock for Q3 2019, down 56% quarter-over-quarter.
  • 11 funds opened new CASTLIGHT HEALTH, INC. positions in Q3 2019 and 23 closed out, a net change of -12 holders.
  • The largest CASTLIGHT HEALTH, INC. buyer in Q3 2019 was Raging Capital Management, an estimated $10.3M added.
  • The largest CASTLIGHT HEALTH, INC. seller in Q3 2019 was Paradigm Capital Management Inc, an estimated $3.02M sold.

Based on aggregated 13F filings for Q3 2019.